Aaltonen KE, Novosadová V, Bendahl PO, Graffman C, Larsson AM, Rydén L. Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy. Oncotarget. 2017;8(28):45544.

Article  PubMed  PubMed Central  Google Scholar 

Abbastabar M, Sarfi M, Golestani A, Karimi A, Pourmand G, Khalili E. Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer. EXCLI J. 2020;19:301.

PubMed  PubMed Central  Google Scholar 

Abe T, Nakashima C, Sato A, Harada Y, Sueoka E, Kimura S, Kawaguchi A, Sueoka-Aragane N. Origin of circulating free DNA in patients with lung cancer. PLoS ONE. 2020;15(7): e0235611.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allory Y, Beukers W, Sagrera A, Flández M, Marqués M, Márquez M, et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol. 2014;65(2):360–6. https://doi.org/10.1016/j.eururo.2013.08.052.

Article  CAS  PubMed  Google Scholar 

Almodovar K, Iams WT, Meador CB, Zhao Z, York S, Horn L, Yan Y, Hernandez J, Chen H, Shyr Y, Lim LP. Longitudinal cell-free DNA analysis in patients with small cell lung cancer reveals dynamic insights into treatment efficacy and disease relapse. J Thorac Oncol. 2018;13(1):112–23.

Article  CAS  PubMed  Google Scholar 

Alunni-Fabbroni M, Rönsch K, Huber T, Cyran CC, Seidensticker M, Mayerle J, Pech M, Basu B, Verslype C, Benckert J, Malfertheiner P. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial. J Transl Med. 2019;17:1–5.

Article  CAS  Google Scholar 

Amantini C, Maggi F, Rossi de Vermandois JA, Gubbiotti M, Giannantoni A, Mearini E, et al. The prognostic value of the circulating tumor cell-based four mRNA scoring system: a new non-invasive setting for the management of bladder cancer. Cancers (Basel). 2022;14(13):3118. https://doi.org/10.3390/cancers14133118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andreu Z, Otta Oshiro R, Redruello A, López-Martín S, Gutiérrez-Vázquez C, Morato E, et al. Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression. Eur J Pharm Sci. 2017;98:70–9. https://doi.org/10.1016/j.ejps.2016.10.008.

Article  CAS  PubMed  Google Scholar 

Ashoor G, Syngelaki A, Poon LCY, Rezende JC, Nicolaides KH. Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks’ gestation: relation to maternal and fetal characteristics: fetal fraction in maternal plasma cell-free DNA. Ultrasound Obstet Gynecol. 2013;41(1):26–32. https://doi.org/10.1002/uog.12331.

Article  CAS  PubMed  Google Scholar 

Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update. Eur Urol. 2016;71(3):447–61. https://doi.org/10.1016/j.eururo.2016.05.041.

Article  PubMed  Google Scholar 

Beckham CJ, Olsen J, Yin P-N, Wu C-H, Ting H-J, Hagen FK, et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J Urol. 2014;192(2):583–92. https://doi.org/10.1016/j.juro.2014.02.035.

Article  CAS  PubMed  Google Scholar 

Berrondo C, Flax J, Kucherov V, Siebert A, Osinski T, Rosenberg A, Fucile C, Richheimer S, Beckham CJ. Expression of the long non-coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes. PLoS ONE. 2016;11(1): e0147236.

Article  PubMed  PubMed Central  Google Scholar 

Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES. Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24.

Article  PubMed  PubMed Central  Google Scholar 

Birkenkamp-Demtröder K, Nordentoft I, Christensen E, Høyer S, Reinert T, Vang S, et al. Genomic alterations in liquid biopsies from patients with bladder cancer. Eur Urol. 2016;70(1):75–82. https://doi.org/10.1016/j.eururo.2016.01.007.

Article  CAS  PubMed  Google Scholar 

Bosschieter J, Nieuwenhuijzen JA, Hentschel A, van Splunter AP, Segerink LI, Vis AN, et al. A two-gene methylation signature for the diagnosis of bladder cancer in urine. Epigenomics. 2019;11(3):337–47. https://doi.org/10.2217/epi-2018-0094.

Article  CAS  PubMed  Google Scholar 

Botezatu I, Serdyuk OG, Potapova G, Shelepov V, Alechina R, Molyaka Y, Ananev V, Bazin I, Garin A, Narimanov M, Knysh V. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem. 2000;46(8):1078–84.

Article  CAS  PubMed  Google Scholar 

Brinkerhoff H, Kang AS, Liu J, Aksimentiev A, Dekker C. Multiple rereads of single proteins at single–amino acid resolution using nanopores. Science. 2021;374(6574):1509–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bronkhorst AJ, Ungerer V, Holdenrieder S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019;17: 100087.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bu J, Lee TH, Jeong W-J, Poellmann MJ, Mudd K, Eun HS, et al. Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer. PLoS ONE. 2020;15(12): e0242145. https://doi.org/10.1371/journal.pone.0242145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Byrnes SA, Chang TC, Huynh T, Astashkina A, Weigl BH, Nichols KP. Simple polydisperse droplet emulsion polymerase chain reaction with statistical volumetric correction compared with microfluidic droplet digital polymerase chain reaction. Anal Chem. 2018;90(15):9374–80.

Article  CAS  PubMed  Google Scholar 

Cai Q, Wu Y, Guo Z, Gong R, Tang Y, Yang K, Li X, Guo X, Niu Y, Zhao Y. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies. Oncotarget. 2015;6(35):37500.

Article  PubMed  PubMed Central  Google Scholar 

Carrasco R, Ingelmo-Torres M, Gómez A, Trullas R, Roldán FL, Ajami T, et al. Cell-free DNA as a prognostic biomarker for monitoring muscle-invasive bladder cancer. Int J Mol Sci. 2022;23(19):11732. https://doi.org/10.3390/ijms231911732.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carvalho S, Abreu CM, Ferreira D, Lima L, Ferreira JA, Santos LL, et al. Phenotypic analysis of urothelial exfoliated cells in bladder cancer via microfluidic immunoassays: Sialyl-Tn as a novel biomarker in liquid biopsies. Front Oncol. 2020;10:1774. https://doi.org/10.3389/fonc.2020.01774.

Article  PubMed  PubMed Central  Google Scholar 

Casadio V, Calistri D, Salvi S, Gunelli R, Carretta E, Amadori D, et al. Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study. Biomed Res Int. 2013;2013: 270457. https://doi.org/10.1155/2013/270457.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casadio V, Salvi S, Martignano F, Gunelli R, Ravaioli S, Calistri D. Cell-free DNA integrity analysis in urine samples. J Vis Exp. 2017. https://doi.org/10.3791/55049.

Article  PubMed  PubMed Central  Google Scholar 

Castella V, Dimo-Simonin N, Brandt-Casadevall C, Mangin P. Forensic evaluation of the QIAshredder/QIAamp DNA extraction procedure. Forensic Sci Int. 2006;156(1):70–3. https://doi.org/10.1016/j.forsciint.2005.11.012.

Article  CAS  PubMed  Google Scholar 

Chakraborty A, Dasari S, Long W, Mohan C. Urine protein biomarkers for the detection, surveillance, and treatment response prediction of bladder cancer. Am J Cancer Res. 2019;9(6):1104–17.

CAS  PubMed  PubMed Central  Google Scholar 

Chan B, Manley J, Lee J, Singh SR. The emerging roles of microRNAs in cancer metabolism. Cancer Lett. 2015;356(2):301–8.

Article  CAS  PubMed  Google Scholar 

Chan KCA, Zhang J, Hui ABY, Wong N, Lau TK, Leung TN, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004;50(1):88–92. https://doi.org/10.1373/clinchem.2003.024893.

Article  CAS  PubMed  Google Scholar 

Chang HW, Tsui KH, Shen LC, Huang HW, Wang SN, Chang PL. Urinary cell-free DNA as a potential tumor marker for bladder cancer. Int J Biol Markers. 2007;22(4):287–94. https://doi.org/10.5301/jbm.2008.4356.

Article  CAS  PubMed  Google Scholar 

Chauhan PS, Chen K, Babbra RK, Feng W, Pejovic N, Nallicheri A, Harris PK, Dienstbach K, Atkocius A, Maguire L, Qaium F. Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: a cohort study. PLoS Med. 2021;18(8): e1003732.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen D, Xu T, Wang S, Chang H, Yu T, Zhu Y, Chen J. Liquid biopsy applications in the clinic. Mol Diagn Ther. 2020;24:125–32.

Article  CAS  PubMed